Replies to post #597377 on NorthWest Biotherapeutics Inc (NWBO)

[NotSure2]

25 September 2023= Submission done just before that (hopefully)

21 December: CHM meeting, 5 month ish clock start

~ June/July 2024 UK approval.

[Springbok80]

It will be sooner.

[Poor Man -]

This is pretty bad, anyway you cut it.

Q4 2023 in my opinion seems very realistic for UK approval. It could be sooner.

Three years after data lock, no guidance or communication from management, and expenses and the dilution to pay for all of this keep piling on. And even worse yet, the company has to have no credibility in the investment community, all things considered. Feel sorry for George trying to explain this company and its “leadership” to prospective investors, who probably think he’s lost his mind to rep these yokels.

Strangely enough, the one company that’s making money and profitable is Advent. How can we buy stock in this business?